Mechanism of follicular trapping: localization of immune complexes and cell remnants after elimination and repopulation of different spleen cell populations.

di Laman, J D, Kors, N, Van Rooijen, N, Claassen, E
Pubblicazione 1990

CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.

di Gerritse, K, Laman, J D, Noelle, R J, Aruffo, A, Ledbetter, J A, Boersma, W J, Claassen, E
Pubblicazione 1996

Pro-inflammatory cytokines in cryptoglandular anal fistulas

di van Onkelen, R. S., Gosselink, M. P., van Meurs, M., Melief, M. J., Schouten, W. R., Laman, J. D.
Pubblicato in Tech Coloproctol (2016)

Brain microbiota disruption within inflammatory demyelinating lesions in multiple sclerosis

di Branton, W. G., Lu, J. Q., Surette, M. G., Holt, R. A., Lind, J., Laman, J. D., Power, C.
Pubblicato in Sci Rep (2016)

Ganglioside Mimicry of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity in Rabbits

di Ang, C. W., Noordzij, P. G., de Klerk, M. A., Endtz, H. P., van Doorn, P. A., Laman, J. D.
Pubblicazione 2002

Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.

di Green, K A, Crassi, K M, Laman, J D, Schoneveld, A, Strawbridge, R R, Foy, T M, Noelle, R J, Green, W R
Pubblicazione 1996

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable d...

di Laman, J D, Schellekens, M M, Abacioglu, Y H, Lewis, G K, Tersmette, M, Fouchier, R A, Langedijk, J P, Claassen, E, Boersma, W J
Pubblicazione 1992

Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable d...

di Laman, J D, Schellekens, M M, Abacioglu, Y H, Lewis, G K, Tersmette, M, Fouchier, R A, Langedijk, J P, Claasen, E, Boersma, W J
Pubblicazione 1992

Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients

di Schrijver, I A, De Man, Y A, Melief, M -J, Van Laar, J M, Markusse, H M, Klasen, I S, Hazenberg, M P, Laman, J D
Pubblicazione 2001

Guillain-Barré Syndrome- and Miller Fisher Syndrome-Associated Campylobacter jejuni Lipopolysaccharides Induce Anti-GM(1) and Anti-GQ(1b) Antibodies in Rabbits

di Ang, C. W., De Klerk, M. A., Endtz, H. P., Jacobs, B. C., Laman, J. D., van der Meché, F. G. A., van Doorn, P. A.
Pubblicazione 2001

Localization in situ of costimulatory molecules and cytokines in B-cell non-Hodgkin's lymphoma.

di Vyth-Dreese, F A, Boot, H, Dellemijn, T A, Majoor, D M, Oomen, L C, Laman, J D, Van Meurs, M, De Weger, R A, De Jong, D
Pubblicazione 1998

Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients

di Ang, C. W., Laman, J. D., Willison, H. J., Wagner, E. R., Endtz, H. P., De Klerk, M. A., Tio-Gillen, A. P., Van den Braak, N., Jacobs, B. C., Doorn, P. A. Van
Pubblicazione 2002